COVID-19 infection increases pro-inflammatory cytokines, leading to cytokine release syndrome (CRS), characterized by increased levels of interferon (IFN)-γ, interleukin-6 (IL-6), and other cytokines, which results in immune hyperactivation. The gene discussed is IL6; the disease is congenital rubella syndrome.